x
Filter:
Filters applied
- JTO: Editors Choice
- SurvivalRemove Survival filter
- Postoperative radiotherapyRemove Postoperative radiotherapy filter
Publication Date
Please choose a date range between 2016 and 2018.
Author
- Billiet, Charlotte1
- Bulens, Paul1
- de Leyn, Paul1
- de Ruysscher, Dirk1
- Decaluwé, Herbert1
- Deng, Weiye1
- Deroose, Christophe M1
- Dooms, Christophe1
- Hendrikx, Marc1
- Karim, Rezaul1
- le Péchoux, Cécile1
- Liao, Zhongxing1
- Liu, Xiangyu1
- Mebis, Jeroen1
- Peeters, Stéphanie1
- Vansteenkiste, Johan1
- Wang, Yifan1
- Xu, Ting1
- Xu, Yujin1
- Yang, Pei1
- Zhao, Yu1
Editors Choice
2 Results
- Brief ReportOpen Archive
Survival Patterns for Patients with Resected N2 Non–Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach
Journal of Thoracic OncologyVol. 13Issue 12p1968–1974Published online: September 4, 2018- Weiye Deng
- Ting Xu
- Yujin Xu
- Yifan Wang
- Xiangyu Liu
- Yu Zhao
- and others
Cited in Scopus: 22The positive-to-resected lymph node ratio (LNR) predicts survival in many cancers, but little information is available on its value for patients with N2 NSCLC who receive postoperative radiotherapy (PORT) after resection. We tested the applicability of prognostic scoring models and heat mapping to predict overall survival (OS) and cancer-specific survival (CSS) in patients with resected N2 NSCLC and PORT. - Original Article Non–Small Cell Lung CancerOpen Archive
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection
Journal of Thoracic OncologyVol. 11Issue 11p1940–1953Published online: July 5, 2016- Charlotte Billiet
- Stéphanie Peeters
- Herbert Decaluwé
- Johan Vansteenkiste
- Christophe Dooms
- Christophe M. Deroose
- and others
Cited in Scopus: 15We investigated patients with contemporarily staged and treated stage III-N2 NSCLC treated with induction chemotherapy and surgery with or without postoperative radiotherapy (PORT). We focused on survival and toxicity and investigated what additional PORT may offer in patients with ypN2 status or incomplete resection.